Table 2. Patient information for survival analysis.

#	Sex	Age	Tumor stage and grade	Tissue source	Intravesical therapy	Neoadjuvant chemotheraphy	Recurrence	Death
1	M	54	T1	TURB	BCG	N/A	Y	Y
2	M	60	Ta (Low)	TURB	MMC	N/A	Y	N
3	M	55	Ta (High)	TURB	BCG	N/A	Y	N
4	M	51	Ta (Low)	TURB	BCG	N/A	Y	N
5	M	76	Ta (High)	TURB	BCG	N/A	N	N
6	M	71	Ta (High)	TURB	MMC	N/A	N	N
7	M	58	Ta (Low)	TURB	x	N/A	N	N
8	M	83	Ta (High)	TURB	BCG	N/A	N	N
9	M	71	T3a (High) N2	TURB	BCG	N	Y	Y
10	M	76	T1 (High)	TURB	N	N/A	N	N
11	M	80	T1 (High)	TURB	N	N/A	Y	Y
12	M	73	T1 (High)	TURB	BCG	N/A	Y	N
13	M	85	T1 (High)	TURB	BCG	N/A	Y	N
14	M	84	T1 (High)	TURB	BCG	N/A	N	N
15	M	83	T1 (High)	TURB	BCG	N/A	N	N
16	M	79	T1 (High)	TURB	BCG	N/A	N	N
17	M	65	T4a (High) N0	TURB	N	N	Y	Y
18	M	84	T1 (High)	TURB	N	N/A	N	Y
19	M	79	Tis N0	TURB	N	N	N	N
20	M	68	T1 N0	TURB	N	Y	N	N
21	M	69	T3b (High) N0	TURB	N	N	N	Y
22	M	86	T2 (High)	TURB	N	N/A	Y	N
23	M	80	T3b (High) N0	TURB	N	N	N	Y
24	M	70	T3b (High) N0	TURB	N	Y	N	Y
25	M	61	T0 N0	Cystectomy	BCG	Y	Y	N
26	M	65	T1 (High) N0	Cystectomy	N	N	N	N
27	M	53	T2b (High) N0	TURB	N	N	N	N
28	M	62	T3b (High) N2	Cystectomy	N	N	N	Y
29	M	70	T1 N1	TURB	N	N	N	N
30	M	43	T2a (High) N2	Cystectomy	Gemcitabine/Cisplatin, BCG	N	Y	N
31	M	60	T2a (High) N0	TURB	N	N	N	N
32	F	66	T1 (High) N2	Cystectomy	N	N	N	N
33	M	66	Tis N0	TURB	N	Y	N	N
34	M	59	T3 (High)	Cystectomy	N	N	Y	N
35	F	57	T0 N0	TURB	N	N	N	N
36	F	49	T2b (High) N0	TURB	N	N	N	N
37	M	77	Tis N0	TURB	N	N	N	N
38	M	72	T0 N0	TURB	N	N	N	Y
39	F	76	T2a (High) N0	Cystectomy	N	N	N	N
40	F	75	T3a (High) N0	TURB	N	N	N	N
41	F	77	T3b (High) N0	Cystectomy	N	N	N	N